Companies /Basic Materials

Ecolab Inc

NYSE: ECL Specialty Chemicals
$278.15
▼ $1.13 (−0.40%) today
Markets closed · 4:23pm ET

Q2 2026 Earnings

Reported Jul 28, 2026, 8:01am ET · SEC source
$2.09
Beat +0.48%
EPS · est. $2.08
$4.4B
Beat +0.63%
Revenue · est. $4.4B
−3.0%
Trailing market
ECL vs S&P since report
3 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
0+2%+4%Jul 28Jul 29report 8:01am ETearnings−0.2%+3.2%
0+2%+4%Jul 28Jul 29earnings−0.2%+3.2%
ECL +3.2%S&P 500 −0.2%
−2%0+2%+4%Jul 28Jul 29report 8:01am ETearnings−0.5%+3.2%
−2%0+2%+4%Jul 28Jul 29earnings−0.5%+3.2%
ECL +3.2%NASDAQ −0.5%
−2%0+2%+4%Jul 27Aug 5report 8:01am ETearnings+5.0%+3.7%
−2%0+2%+4%Jul 27Aug 5earnings+5.0%+3.7%
ECL +3.7%S&P 500 +5.0%
−3%0+3%+6%Jul 27Aug 5report 8:01am ETearnings+7.5%+3.7%
−3%0+3%+6%Jul 27Aug 5earnings+7.5%+3.7%
ECL +3.7%NASDAQ +7.5%
+4.24%
Day of report
+0.28%
Next session
+0.08%
One week
+1.06%
30 days

S&P 500 over the same 30 days: +4.08%.

Did ECL Beat Earnings? Q2 2026 Results

Ecolab posted a clean beat across both top and bottom lines in the second quarter of 2026, with adjusted diluted EPS of $2.09 edging past the $2.08 consensus estimate by 0.48% and revenue of $4.42 billion topping expectations by 0.63% on a 9.7% year-over-year gain. The standout driver behind the quarter was accelerating momentum in the company's high-growth platforms, particularly Life Sciences, where organic revenue climbed 15% and operating income surged 46%, with margins expanding 550 basis points to 26.5%. Organic sales growth of 5%, a mix of 1% volume and 4% pricing, helped offset a roughly 1% volume headwind tied to customer disruptions from the Middle East conflict. Ahead of the print, investors had been closely watching whether Ecolab could sustain pricing gains while expanding margins, and the quarter delivered on both fronts. Management raised full-year 2026 adjusted EPS guidance to $8.05 to $8.25, representing 7% to 10% growth, and pointed to second-half organic sales acceleration toward 6% to 7%.

Key Takeaways
  • Accelerating organic sales growth of 5%, driven by 1% volume and 4% pricing improvement
  • Energy surcharge implementation mitigating rising commodity costs
  • 29% organic growth in Global High-Tech across microelectronics and data centers
  • 15% organic growth in Life Sciences driven by bioprocessing share gains
  • One Ecolab enterprise growth strategy driving new business wins across segments
  • Strong productivity gains offsetting growth-oriented investments
  • Favorable currency translation contributing $0.04 per share to adjusted diluted EPS

“We delivered another quarter of double-digit EPS growth, driven by strong execution across the company which produced accelerating organic sales growth, a stable organic gross margin excluding the impact from Ovivo Electronics, and strong productivity. Reported volume grew 1%, despite a nearly 1% headwind from customer operations disrupted by the conflict in the Middle East, while underlying volume growth strengthened. Pricing improved to 4%, reflecting the early benefits of our energy surcharge implementation, which helped to mitigate the impact of rising commodity costs. This strong performance demonstrates the durability of our growth model and the power of our global team to deliver for our customers no matter what.”

Ecolab CEO, on the earnings call

Forward Guidance & Outlook

Ecolab raised its full-year 2026 adjusted diluted EPS outlook to $8.05-$8.25, representing 7%-10% growth, up from prior expectations of $8.03-$8.23. For Q3 2026, the company expects adjusted diluted EPS of $2.13-$2.23, up 3%-8% year-over-year. Second half 2026 reported sales growth is expected at 12%-14%, with organic sales growth accelerating to 6%-7%. The company anticipates second half adjusted operating income margin of approximately 19% and organic operating income margin of approximately 20%. Pricing in the second half is expected to be in the 5%-6% range. Long-term targets include organic sales growth of 5%-7%, operating income margin expansion of 100-150 bps per year toward exceeding 20%, and adjusted EPS growth of 12%-15%. The company expects quantifiable special charges of approximately $0.75-$0.80 per share for full-year 2026. These outlook ranges reflect strong underlying performance offset by short-term non-cash amortization and financing costs from the CoolIT acquisition.

ECL YoY Financials

Q2 2026 vs Q2 2025 · SEC filings Q2 2025 Q2 2026
$0$2.0B$4.0B$4.0B$4.4BRevenue$1.8B$1.9BGross Profit$710.1M$757.9MOperating Income$524.2M$534.9MNet Income
$0$2.0B$4.0BRevenueGross ProfitOperating IncomeNet Income

ECL Revenue by Segment

Global Water$2.2B+12.0%
Global Institutional & Specialty$1.6B+5.0%
Global Pest Elimination$351.1M+11.0%
Global Life Sciences$220.1M+18.0%
Ecolab Digital$121.0M+27.0%

Figures from SEC filings and company reports. Not investment advice.